|
|
|
Clinical Trials at Dana-Farber/Harvard Cancer Center
Phase II Trial of MTA Administered Intravenously Every 21 Days
in Patients With Malignant Pleural Mesothelioma (offered at Dana-Farber
Cancer Institute, Brigham & Women's Hospital and Massachusetts General
Hospital)
Phase I Trial of Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal
Heated Cisplatin and Intravenous Sodium Thiosulphate in the Multimodality
Treatment of Malignant Pleural Mesothelioma (offered at Dana-Farber
Cancer Institute and Brigham & Women's Hospital)
Phase I Trial of Extrapleural Pneumonectomy Followed by Intrathoracic/Intraperitoneal
Heated Cisplatin and Intravenous Sodium Thiosulfate in the Multimodality
Treatment of Malignant Pleural Mesothelioma (offered at Dana-Farber
Cancer Institute and Brigham & Women's Hospital)
Phase II Study of Capecitabine in Patients With Malignant Mesothelioma